Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on PORTA COMMUNICATIONS PLC. We currently have 4 research reports from 2 professional analysts.
|16Feb17 11:14||RNS||Issue of Additional Consideration Shares|
|08Feb17 11:25||RNS||TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES|
|01Feb17 07:00||RNS||TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES|
|31Jan17 07:00||RNS||TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES|
|27Jan17 07:00||RNS||Conversion of Retro Grand Debt|
|22Dec16 07:00||RNS||TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES|
|07Dec16 07:00||RNS||Acquisition of additional interest|
Frequency of research reports
Research reports on
PORTA COMMUNICATIONS PLC
PORTA COMMUNICATIONS PLC
Small Cap Breakfast
27 Jan 17
Rainbow Rare Earths has published a prospectus. It has raised $8m to fast-track fully permitted high grade Gakara ‘rare earths’ project to production in Burundi. Intends to join the Standard List of the LSE. Impact healthcare REIT— Intends to float on the main market. Seeks to raise £160m to acquire a portfolio of up to 58 care homes. Expected Admission 7 March. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.
29 Sep 16
Cambridge Cognition Holdings* (COG.L) | Edenville Energy (EDL.L) | Avingtrans (AVG.L) | Gaming Realms (GMR.L) | Redstone Connect (REDS.L) | Concurrent Technologies (CNC.L) | Porta Communications (PTCM.L) | Galantas Gold (GAL.L) | Range Resources (RRL.L) | Plutus Power Gen (PPG.L)
05 Aug 16
Audioboom (BOOM.L) | Cloudcall (CALL.L) | Porta Communications (PTCM.L) | S y m p h o n y E n v i r o n m e n t a l Technologies (SYM.L) | Blue Prism Group (PRSM.L) | B e n c h m a r k Holdings (BMK.L) | Bexi mco P harm a (BXP.L) | S t e r l i n g E n e r g y ( S E Y . L ) | AFC Energy (20.75.L) | PHSC (PHSC.L)
A Solid Platform For Future Growth
10 Mar 16
In the past five years, Porta Communications has built a multi-capability global communications platform through organic start-ups and acquisitions. It has generated significant organic growth and has recently reported its first positive operating cash flow. There is much more to be done and the group has re-inforced its senior management team to allow sustained focus on generating growth within the existing client portfolio while continuing to identify strategic opportunities to expand. Profitability is improving rapidly and net debt is forecast to fall. We have initiated coverage ahead of the full year results announcement due in May, the positives of which were highlighted in the recent trading update. The shares are trading on a 54% discount to the wider media sector average.
N+1 Singer - Morning Song 22-02-2017
22 Feb 17
CORETX (COR LN) Contract wins and new Lifestyle facility | Gooch & Housego (GHH LN) Solid Q1 trading plus earnings enhancing acquisition of StingRay Optics | NCC Group (NCC LN) Further issues in Assurance | PCI-PAL (PCIP LN) Strong H1 underpins positive outlook | UBM (UBM LN) Results | Verona Pharma (VRP LN) Phase IIa RPL554 add-on trial to tiotropium commenced
N+1 Singer - Morning Song 23-02-2017
23 Feb 17
Genus (GNS LN) Interim results: R&D step-up, disappointing ABS performance | Howden Joinery Group (HWDN LN) Prelims and net cash better than expected but conditions weaken | Oxford Pharmascience Group (OXP LN) Encouraging interim OXPzero™ Ibuprofen exploratory PK data | StatPro Group (SOG LN) Increased majority shareholding in Infovest Consulting | Wilmington Group (WIL LN) Interims slightly ahead, move to focus on 3 verticals
Another positive financial performance in FY16
23 Feb 17
As expected, RELX produced satisfactory FY 16 results, with organic revenue growth positively accelerating to +4% (FY15 at +3%). Consolidated revenues reached £6,895m (+15%) after a total forex impact of +11%, reflecting the weakness in sterling versus both the US dollar and euro (only 7.3% of sales in the UK). The group’s adjusted OP amounted to £2,114m, up 6% organically (+16% reported) and reflecting an improving margin to 30.7% from 30.5% in FY15, although slightly under our 31% expectation. The adjusted EPS increased by 8% at CER to 72.2p (AV: 71.8p). The full-year dividend is raised 21% to 35.95p (AV at 34.8p) after a final at 25.7p from 22.3p a year earlier (as a reminder, the group had announced in August a larger than usual interim dividend primarily due to end-period forex). RELX announced a new £700m share buy-back programme for FY17e (£100m completed so far) after £700m completed in FY16 and is confident to deliver in FY17e “another year of underlying revenues, profit and earnings growth”, a positive statement although as vague as usual.
N+1 Singer - Small-cap quantitative research - New quality style screen + 11 quality focus stocks
09 Feb 17
We introduce our fourth and final style screen representing “quality”. This screens for stocks with the best combination of high returns on capital/equity, EBIT margins and operating cash-flow conversion rates. These criteria should help us monitor how strong underlying returns translate into share price performance over time and under varying market conditions. The screen selects the “best” 25 stocks from our universe of just over 500 stocks and, as usual, we focus on a shorter list of stocks we cover or otherwise know and believe to be particularly interesting. We provide brief investment summaries on these focus stocks on pages 4 – 9. We will monitor performance and refresh the screen in approximately 3-4 months time.
Solid organic growth and significant improvement in profitability
22 Feb 17
Wolters Kluwer reported FY16 revenues of €4,297m, up 2% and in line with our forecast of €4,300m (+3% organically, i.e. positively accelerating from the +2% in the first 9 months, and similar to FY15) as well as a 22.1% adjusted operating margin, up 70bp from 21.4% a year earlier and slightly above expectations (as a reminder the group’s guidance was for between 21.5% and 22%; AV’s was 21.6%). This was after restructuring expenses of €29m. The adjusted net profit was €618m, above our €604m expectations, i.e. diluted adjusted EPS of €2.10, up 7% and versus our €2.04. The group generated a solid €708m FCF in FY16, up 9% at CER and ended the year with a strong financial position (net debt/EBITDA ratio of 1.7x). The proposed FY16 total dividend is up 5% to €0.79/share.